Latest news from FANUC UK Ltd

All-electric injection presses form part of £7m 'future view' investment at Owen Mumford Ltd.

10 December 2013

Owen Mumford, one of the UK’s leading companies in the supply and manufacture of specialist medical devices, has invested in all-electric injection moulding presses for its 'Phase 5' manufacturing facility, now close to completion, at the firm’s Chipping Norton site.

The all-electric moulding presses include 5 FANUC ROBOSHOT moulding machines and 4 FANUC 6 axes robots.

The presses form part of a £7million investment by Owen Mumford and represents its vision of future needs for medical device manufacturing excellence. 

Comprising a 1,000m2 clean room area, in a purpose-built facility, Owen Mumford’s Manufacturing team has maximised on this 'ground-up' opportunity to project design and implement the latest technology and thinking for clean room manufacturing facility design.

Group Operations Director, Modestino Graziano, commented, "Best in class manufacturing facilities, along with a clear focus on manufacturing excellence are minimum requirements for our industry.  We based 'Phase 5' on  the high standards our clients expect, on the requirements to meet future industry regulations and our team's extensive experience of manufacturing for this sector.

"For example, the facility has been developed with energy savings in mind;  and from our  past experience of FANUC ROBOSHOT all-electric injection moulding machines, we know the total cost profile of electric machines is lower than that of hydraulic machines".

FANUC ROBOSHOT injection moulders were the first all-electric moulding machines available when they were introduced to the market in the early 1980s and to date it is believed they remain the only moulders available that are designed from the ground up as  all-electric machines; other electric machines are based on hydraulic platform designs. 

Since their introduction, precision, monitoring, control and energy saving ability have been FANUC's continual development driving force for their injection moulding machine range.

The five ROBOSHOT S-2000 i250B injection moulding machines are ideal for the precise nature of medical device delivery systems where thin wall and ultra precision moulding is required.  Incorporating its newly developed high power servo motor into the injection unit allows injection speeds of up to 1,000 mm/s to be acheived together with accurately monitored high clamping pressure.

High-quality and stable moulding is maintained by precise backflow monitoring, metering and the rigid construction of the machines.  Overall machine control is provided by FANUC's latest control technology based on its CNC control platform used across all FANUC product lines.

Flexibility of integration of equipment, within the project, has been critical for the Owen Mumford team to achieve their ultimate goals, "Throughout the project, FANUC has been happy to help which  is  crucial to smooth the project implementation process.  The integration of the hot runner systems to each machine was made straightforward by FANUC's support, combined with the flexible and open nature of the FANUC control system," explained Graziano .

Adding to the 'Future View' capability of 'Phase 5' will be the new FANUC M-20iA robots which have the six axes flexibilty to undertake load and unload tasks from the moulding machines together with second operation assembly tasks if required.  Using the same control platform as the ROBOSHOT moulding machines, the M-20iA robots have a payload capacity of 20 kgs providing adequate scope for future end of arm tooling requirements.

Other Press Releases By This Company

Released By


Related Categories

Related Industry Sectors